International Markets

In what international markets do you anticipate significant developments in the near future?

Pharma's Almanac

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

Recombinant Proteins

The Expanding Role for Recombinant Proteins in Research

Rob Burgess, Ph.D.

Sino Biological

Three Benefits of Using In Silico Technologies for Drug Discovery

Kimberly Brunner

Immuno-Oncology

Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology

Dan Passeri, M.Sc., J.D.

Cue Biopharma

CAR-T

Enabling Greater Patient Access to CAR-T Cell Therapies with Off-the-Shelf Delivery Solutions

Ryan Larson, Ph.D.

Synthetic Biology

Synthetic Biology: A Potential Game-Changer for the Biopharma Industry

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Digital Therapeutics

Digital Therapeutics and the Song of the Future of Healthcare

Chris E. Rivera; Xavier A. Figueroa

EMulate Therapeutics

PLIs

A Strategic Approach to Pre-License Inspections

William Leonardi, Ph.D.

Avid Bioservices

Computational Drug Design

Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery

Ronald Dorenbos, Ph.D.; Guido Lanza

Charles River Laboratories

3D Printing

Advancing Extrusion-Based 3D Printing for Drug Production

Thomas Kipping, Ph.D.; Xianghao Zuo, Ph.D.

MilliporeSigma

Sweeteners

High-Intensity Sweeteners for Taste Optimization

Almut von der Brelie

MilliporeSigma

One Medicine

Revisiting Comparative Drug Development

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Hemostatic

Stopping Bleeds and Saving Lives

Joe Landolina

Cresilon

mRNA Manufacturing

Investing in the Future of mRNA Manufacturing

Esther Yoo, Ph.D.

Samsung Biologics

Inhalation Vaccines

The Exciting Potential of Inhalation Vaccines

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Viral Vector Manufacturing

Optimizing Transient Transfection for Viral Vector Production

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Robotic Sterile Fill-Finish

Accelerating Drug Development Using Robotic Sterile Fill-Finish Platforms

Jeff Clement; Mark Shepanski

PCI Pharma Services

Cell Therapy

Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making

Chris McClain

Be The Match BioTherapies

mRNA Manufacture

Platform Processes and End-to-End Capabilities Position Vernal Biosciences as a Critical CDMO Resource for mRNA Developers

Tonia Becker

Nice Insight